Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Rein Therapeutics, Inc. (RNTX)

NASDAQ

$0.86

$-0.02

(-2.31%)

Pre-Market

Rein Therapeutics, Inc. (RNTX) Live Price Chart

Last updated: ⁦2026-09-09 10:37:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Rein Therapeutics, Inc. (RNTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.86, with a market capitalization of $76.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.69 to $2.18. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$76.70M
Open	$0.93
Day's High	$3.50
Day's Low	$0.69
Previous Close	$0.89
Volume	754.47K
Average Volume	513.32K
P/E Ratio	--
52-Week High	$2.18
52-Week Low	$0.69
Dividend Yield	--
Earnings Date	--

Rein Therapeutics, Inc. (RNTX) Pre-Market Stock Price

Rein Therapeutics, Inc. (RNTX) is trading at $0.90 in pre-market trading as of 2026-09-08 23:35:00, up 1.34% ($0.01) from the previous close of $0.89

Pre-market trading shows how investors are pricing RNTX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Rein Therapeutics, Inc. (RNTX) 7-Day Stock Price Change

Over the past seven days, Rein Therapeutics, Inc. (RNTX) moved from $0.76 to $0.86, representing a gain of 12.19% ($0.09).

The stock traded between $0.73 and $0.96 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 565.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

RNTX 52-Week Price Position

Position in Range: 10.8%

52W Low$0.69

52W High$2.18

RNTX is currently trading at $0.86, placing it 10.8% of the way from its 52-week low of $0.69 to its 52-week high of $2.18. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rein Therapeutics, Inc. (RNTX)?

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Rein Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	10
Exchange	NASDAQ
Company Website	https://www.reintx.com

How to Buy Rein Therapeutics, Inc. (RNTX) Stock on MEXC

Eligible investors can buy real shares of Rein Therapeutics, Inc. (RNTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RNTX and Place Your Order

Open the RealStocks trading page and search for RNTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rein Therapeutics, Inc. (RNTX) stock price today?

Rein Therapeutics, Inc. (RNTX) is currently trading at $ 0.86, down 3.84% ($0.03) from the previous close of $ 0.89. Intraday prices update in real time during regular trading hours.

2.Is RNTX stock going up or down today?

As of 2026-09-08 23:35:00, RNTX is trading at $ 0.86, down 3.84% ($0.03) from its previous close of $ 0.89. The stock has traded between $ 0.69 and $ 3.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is RNTX pre-market price?

As of 2026-09-08 23:35:00, RNTX is trading at $ 0.90 in pre-market trading, up 1.34% ($0.01) from the previous close of $ 0.89. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RNTX after-hours price?

As of 2026-09-08 23:35:00, RNTX is trading at $ 0.89 in after-hours trading, up 0.10% ($0.00) from the regular-session close of $ 0.89. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RNTX stock trading now?

RNTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RNTX sit relative to its 52-week high and low?

Over the past 52 weeks, RNTX has traded between a low of $ 0.69 and a high of $ 2.18. At $ 0.86, the stock is positioned 10.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rein Therapeutics, Inc. in?

Rein Therapeutics, Inc. (RNTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rein Therapeutics, Inc.'s market capitalization and where is it listed?

Rein Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 76.70M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RNTX valued in terms of P/E ratio and EPS?

RNTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.58. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rein Therapeutics, Inc. pay a dividend?

Rein Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.